Newsroom > Articles


Clinique Saint Augustin in Bordeaux, France, SurgAR and Medexprim are proud to announce a 4-year strategic partnership to accelerate the development of SurgAR’s augmented reality software dedicated to robot-assisted laparoscopic partial nephrectomy.  

A member of the Elsan group and leader in private hospitalization in France, the Saint Augustin Clinic in Bordeaux has 111 practitioners, including a team of 9 surgeons specializing in urology.

This three-way partnership will allow the constitution of a database of surgical videos to develop Artificial Intelligence tools for the detection and segmentation of the kidney and related anatomical markers. It is a further step in the development of innovative solutions for research and patient well-being.

SurgAR and Medexprim will continue to develop this model with their network of European hospitals, whether they are existing partners of Medexprim or SurgAR. Over the next three years, the solution proposed by the partners will be deployed on 12 sites in France and Europe.

French version of the PR

About Clinique Saint Augustin:
Private clinic belonging to the Elsan group, has a capacity of 200 beds, 13 operating rooms and is equipped with 2 surgical robots, an MRI and a scanner. Its 600 employees, including 111 practitioners, work together to care for more than 16,000 patients per year.

About SurgAR:
SurgAR (Surgical Augmented Reality) is a startup based in Clermont Ferrand whose objective is the development and marketing of augmented reality software for laparoscopic surgery.

SurgAR is a disruptive innovation that revolutionizes current surgical practices and brings the operating room into the next phase of the digital era of augmented reality by integrating computer vision, artificial intelligence and deep learning technologies.
Website – Linkedin

About Medexprim:

Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.
LinkedIn Romain Cazavan

Medexprim Press contact: Anne-Sophie Labeta –

3 questions to Coralie Carron

As a Ph.D. holder in Cellular and Molecular Biology, Coralie Carron assumes the pivotal…

CIAN: Cohort Imaging Analytics Network

Medexprim enables the aggregation, curation and enrichment of multicentric and multimodal cohorts of Real-World…

💡Scientific Insights – Read Samuel Boucher’s Take on the future…

Medexprim’s researchers and engineers contribute daily to the advancement of scientific research. Our researchers…

PR – Medexprim partners with Avicenna.AI to help validate their…

Medexprim, the European leader in multimodal Real-World datasets for clinical research, is pleased to…